Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China

Oncology Reports

Volumn 20, Issue 2, 2008, Pages 333-339

  Wang, Yongping ^a,b   Wang, Aifeng ^b   Jiang, Rui ^c   Pan, Huaxiong ^a   Huang, Bangxing ^a   Lu, Yan ^d   Wu, Cuihuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d XIAMEN UNIVERSITY   (China)

Author keywords

Apoptosis; Human papillomavirus; Non small cell lung cancer; p53; PRb; Proliferation

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS INFECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CHINA; DNA PROBES; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 48749120741     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000011     Document Type: Article

References (39)

1. Wood ME, Kelly K, Mullineaux LG and Bunn PA: The inherited nature of lung cancer: a pilot study. Lung Cancer 30: 135-144, 2000.
2. Charloux A, Quoix E, Wolkove N, Small D, Pauli G and Kreisman H: The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 26: 14-23, 1997.
3. Syrjänen KJ and Syrjänen S: Papillomavirus infection in human pathology. John Wiley & Sons, New York, pp1-10; 355-378, 2000.
4. Syrjänen KJ: Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 38: 299-304, 1979.
5. Syrjänen KJ: Epithelial lesions suggestive of a condylomatous origin found closely associated with invasive bronchial squamous cell carcinomas. Respiration 40: 150-160, 1980.
6. Syrjänen K, Syrjänen S, Kellokoski J, Kärjä J and Mäntyjärvi R: Human papillomavirus (HPV) type 6 and 16 DNA sequences in bronchial squamous cell carcinomas demonstrated by in situ DNA hybridization. Lung 167: 33-42, 1989.
7. Hirayasu T, Iwamasa T, Kamada Y, Koyanagi Y, Usuda H and Genka K: Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 49: 810-817, 1996.
8. Papadopoulou K, Labropoulou V, Davaris P, Mavromara P and Papastamatiou HT: Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch 433: 49-54, 1998.
9. Iwamasa T, Miyagi J, Tsuhako K, Kinjo T, Kamada Y, Hirayasu T and Genka K: Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol Res Pract 196: 209-218, 2000.
10. Miyagi J, Kinjo T, Tsuhako K, Higa M, Iwamasa T, Kamada Y and Hirayasu T: Extremely high langerhans cell infiltration contributes to the favorable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology 38: 355-367, 2001.
11. Aguayo F, Castillo A, Koriyama C, et al: Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 97: 85-91, 2007.
12. Nadji SA, Mokhtari-Azad T, Mahmoodi M, et al: Relationship between lung cancer and human papillomavirus in north of Iran, Mazandaran province. Cancer Lett 248: 41-46, 2007.
13. Cheng Y, Chiou H, Sheu G, et al: The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61: 2799-2803, 2001.
14. Chiou H, Wu M, Liaw Y, Cheng Y, Wong R, Chen C and Lee H: The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 97: 1558-1563, 2003.
15. Cheng Y, Chiou H, Chen J, et al: Gender difference in human papillomavirus infection for non-small cell lung cancer in Taiwan. Lung Cancer 46: 165-170, 2004.
16. Cheng Y, Chen J, Richard K, Chen P and Christiani DC: Lung adenocarcinoma and human papillomavirus infection. Cancer 101: 1428-1436, 2004.
17. Szabó I, Sepp R, Nakomoto K, Maeda M, Sakamoto H and Uda H: Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 73: 2740-2744, 1994.
18. Shamanin V, Delius H and Villiers ED: Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol 75: 1149-1156, 1994.
19. Welt A, Hummel M, Niedobitek G and Stein H: Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. J Pathol 181: 276-280, 1997.
20. Bohlmeyer T, Le TN, Shroyer AL, Markham N and Shroyer KR: Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol 18: 265-269, 1998.
21. Noutsou A, Koffa M, Ergazaki M, Siafakas NM and Spandidos DA: Detection of human papilloma virus (HPV) and K-ras mutations in human lung carcinomas. Int J Oncol 8: 1089-1093, 1996.
22. Clavel CE, Nawrocki B, Bosseaux B, et al: Detection of human papillomavims DNA in bronchopulmonary carcinomas by hybrid capture II: A study of 185 tumors. Cancer 88: 1347-1352, 2000.
23. Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P and Degano B: Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92: 743-746, 2005.
24. Coissard CJ, Besson G, Polette MC, Monteau M, Birembaut P and Clavel CE: Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 18: 1609-1609, 2005.
25. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA and Howley PM: Structural and transcriptional analysis of human papillomovirus type 16 sequences in cervical carcinoma cell lines. J Virol 61: 962-971, 1987.
26. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and Hausen HZ: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111-114, 1985.
27. Thomas M, Pim D and Banks L: The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18: 7690-7700, 1999.
28. Wu EW, Clemens KE, Heck DV and Munger K: The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol 67: 2402-2407, 1993.
29. Montenarh M: Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene 7: 1673-1680, 1992.
30. Bártková J, Bártek J, Lukás J, Vojtesek B, Stasková Z, Rejthar A, Kovarík J, Midgley CA and Lane D: P53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 49: 196-202, 1991.
31. Midgley C, Fisher CJ, Bartek J, Vojtesek B, Lane D and Barnes DM: Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 101: 183-189, 1992.
32. Mantovani F and Banks L: The interaction between p53 and papillomaviruses. Semin Cancer Biol 9: 387-395, 1999.
33. Helt A, Funk JO and Galloway DA: Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J Virol 76: 10559-10568, 2002.
34. Syrjänen KJ: HPV infections and lung cancer. J Clin Pathol 55: 885-891, 2002.
35. Miyagi J, Tsuhako K, Kinjo T, Iwamasa T and Hirayasu T: Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 53: 676-684, 2000.
36. Wang J, Cheng Y, Wu D, Chen J, Chen C, Chou M and Lee H: Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected no-smoking female lung cancer in Taiwan. Cancer Lett 235: 18-25, 2006.
37. INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int J Cancer 113: 440-445, 2005.
38. Cheng Y, Wu M, Wang J, et al: Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 67: 10686-10693, 2007.
39. Kinjo T, Kamiyama K, Chinen K, Iwamasa T, Kurihara K and Hamada T: Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol Pathol 56: 97-108, 2003.